Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Clinical trial NCT04978038 · UNKNOWN

Trial details

NCT number: NCT04978038
Sponsor: Mark Loeb
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

SARS-CoV2 Infection Coronavirus Infection

Start date: 2022-08-01
Primary completion: 2022-11-15
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.